-
Methotrexate treatment hampers induction of vaccine-specific CD4 T cell responses in patients with IMID
Kummer, L. Y. L., Fernández Blanco, L., Kreher, C., Bos, A., Kuijper, L. H., Verstegen, N. J. M., van de Sandt, C. E., Konijn, V. A. L., Duurland, M. C., Menage, C., Jorritsma, T., Steenhuis, M., Hagen, R. R., van den Dijssel, J., de Jongh, R., Ashhurst, T., van Gils, M. J., Garcia-Vallejo, J. J., Claireaux, M. & Stalman, E. W. & 14 others, , 7 Oct 2024, In: RMD open. 10, 4, 12 p., e004664.Research output: Contribution to journal › Article* › Academic › peer-review
-
T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination
T2B! immunity against SARS-CoV-2 study group, Verstegen, N. J. M., Hagen, R. R., Kreher, C., Kuijper, L. H., van den Dijssel, J., Ashhurst, T., Kummer, L. Y. L., Cabeza, V. P., Steenhuis, M., Duurland, M. C., de Jongh, R., van der Schoot, C. E., Konijn, V. A. L., Mul, E., Kedzierska, K., van Dam, K. P. J., Stalman, E. W., Boekel, L. & Wolbink, G. & 31 others, , 16 Aug 2024, In: Journal of Neurology, Neurosurgery and Psychiatry. 95, 9, p. 855-864 10 p., jnnp-2023-332224.Research output: Contribution to journal › Article* › Academic › peer-review
-
mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses
van den Dijssel, J., Duurland, M. C., Konijn, V. A. L., Kummer, L. Y. L., Hagen, R. R., Kuijper, L. H., Wieske, L., van Dam, K. P. J., Stalman, E. W., Steenhuis, M., Geerdes, D. M., Mok, J. Y., Kragten, A. H. M., Menage, C., Koets, L., van der Schoot, C. E., D'Haens, G. R. A., Löwenberg, M., Volkers, A. G. & Rispens, T. & 6 others, , 1 Apr 2024, In: Journal of autoimmunity. 144, 13 p., 103175.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
